Rosalind Advisors, Inc. Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001622627

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q1 2026 · 35 positions · Total reported value $243.99M · Top-10 concentration 67.3% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 54.8% · 9 new · 11 cut · 3 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +4.7% · vs SPY +2.5% · Prev Value $269.06M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -5.8% · vs SPY -7.9% · Latest Value $244.66M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2026 13F filing, Rosalind Advisors, Inc. disclosed 35 equity positions with a combined reported value of $243.99M. The filing implies a focused portfolio: its ten largest positions account for 67.3% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2026 were DCTH ($30.63M), XERS ($18.74M), FENC ($17.89M). By sector, the heaviest allocations are Health Care 93.7%, Industrials 5.5%. Versus the prior quarter, allocation shifted toward Health Care (+4.7pp) and away from Other (-5.2pp).

Versus the prior quarter, Rosalind Advisors, Inc. opened 9 new positions, trimmed 11 and fully exited 3, a turnover rate of 54.8% of positions. The portfolio's overlap with the prior quarter was 51% of names.

The largest new positions opened in Q1 2026 were PCVX ($16.85M), VOR ($12.49M), CLDX ($10.47M).

Of the 3 positions fully exited versus the prior quarter, the largest were ATYR ($13.60M), CYTK ($12.39M), MNMD ($10.04M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2026)

  • PCVX VAXCYTE INC · $16.85M
  • VOR VOR BIOPHARMA INC · $12.49M
  • CLDX CELLDEX THERAPEUTICS INC NEW · $10.47M
  • BCRX BIOCRYST PHARMACEUTICALS INC · $8.79M
  • AVIR ATEA PHARMACEUTICALS INC · $6.30M
  • REPL REPLIMUNE GROUP INC · $2.75M
  • OVID OVID THERAPEUTICS INC · $2.46M
  • DFTX DEFINIUM THERAPEUTICS INC · $2.36M

Fully Exited (vs previous quarter)

  • ATYR ATYR PHARMA INC · prev qtr: $13.60M
  • CYTK CYTOKINETICS INC · prev qtr: $12.39M
  • MNMD MIND MEDICINE MINDMED INC · prev qtr: $10.04M
  • OCUL OCULAR THERAPEUTIX INC · prev qtr: $4.86M
  • AVXL ANAVEX LIFE SCIENCES CORP · prev qtr: $1.88M
  • TRVI TREVI THERAPEUTICS INC · prev qtr: $1.25M
  • GUTS FRACTYL HEALTH INC · prev qtr: $848.61K
  • AVBP ARRIVENT BIOPHARMA INC · prev qtr: $539.50K

Insider Transactions (Form 4)

Latest Rosalind Advisors, Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-10-13 J DELCATH SYSTEMS, INC. 27,502 — SEC filing
2026-10-13 Conversion DELCATH SYSTEMS, INC. 3,627 — SEC filing

All insider transactions →

Fund Profile

Rosalind Advisors, Inc. is an SEC-registered 13F filer. As of Q2 2026 it reported 33 US equity positions with a combined value of $269.06M. HoldingsHub carries 11 quarters of its filings (Q4 2023–Q2 2026).

Portfolio Structure

  • 33 positions · $269.06M reported value (Q2 2026)
  • Top 10 holdings = 74.1% of reported value
  • Largest position: DCTH (DELCATH SYS INC) at 15.4%
  • Average position size: $8.15M

Sector Tilt

  • Health Care 94.7%
  • Industrials 5.3%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 6 new, 7 added, 12 reduced, 8 exited
  • 8 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 93.7%
Other 0.8%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 3.30M $30.63M 12.55%
12.55%
Hold
2 3.23M $18.74M 7.68%
7.68%
Add
3 2.91M $17.89M 7.33%
7.33%
Add
4 3.20M $17.49M 7.17%
7.17%
Reduce
5 290.00K $16.85M 6.91%
6.91%
New
6 1.04M $13.36M 5.48%
5.48%
Add
7 3.21M $13.28M 5.44%
5.44%
Add
8 700.00K $12.49M 5.12%
5.12%
New
9 749.05K $12.07M 4.95%
4.95%
Hold
10 2.14M $11.33M 4.64%
4.64%
Add
11 330.00K $10.47M 4.29%
4.29%
New
12 923.06K $8.79M 3.60%
3.60%
New
13 1.53M $7.35M 3.01%
3.01%
Reduce
14 100.00K $6.77M 2.77%
2.77%
Reduce
15 3.91M $6.37M 2.61%
2.61%
Hold
16 1.17M $6.30M 2.58%
2.58%
New
17 828.12K $5.37M 2.20%
2.20%
Reduce
18 1.28M $2.75M 1.13%
1.13%
New
19 597.93K $2.62M 1.07%
1.07%
Reduce
20 3.85M $2.60M 1.06%
1.06%
Hold
21 3.35M $2.51M 1.03%
1.03%
Reduce
22 1.11M $2.46M 1.01%
1.01%
New
23 125.00K $2.36M 0.97%
0.97%
New
24 443.76K $1.84M 0.75%
0.75%
Reduce
25 221.62K $1.77M 0.73%
0.73%
New
26 286.14K $1.69M 0.69%
0.69%
Hold
27 75.00K $1.12M 0.46%
0.46%
New
28 200.00K $1.11M 0.45%
0.45%
New
29 250.00K $1.05M 0.43%
0.43%
Reduce
30 250.00K $1.04M 0.42%
0.42%
New
31 125.00K $958.50K 0.39%
0.39%
Reduce
32 1.16M $941.64K 0.39%
0.39%
Add
33 100.00K $813.00K 0.33%
0.33%
Hold
34 251.51K $768.36K 0.32%
0.32%
Hold
35 263.60K $52.72K 0.02%
0.02%
Reduce

FAQ

What did Rosalind Advisors, Inc. buy in 2026-Q1?

In its 2026-Q1 13F filing, Rosalind Advisors, Inc. reported 35 equity positions worth $243.99M in aggregate; its largest disclosed positions were DCTH ($30.63M), XERS ($18.74M), FENC ($17.89M).

How large is Rosalind Advisors, Inc.'s portfolio?

Rosalind Advisors, Inc. reported $243.99M of long equity holdings across 35 positions as of 2026-Q1. Top-10 holdings account for 67.3% of reported value.

What is Rosalind Advisors, Inc.'s investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rosalind-advisors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →